Performance in Clinical Research
During the course of the year, the Trust is involved in a wide variety of Clinical trials and research.
- Some of our achievements
Dr Jane Martindale has published her blog on fatigue and the research behind it. Click here to read it.
Highest Recruiting Site in the UK for the SIRROUND T Study
EVIE study – The Hewitt Fertility Centre are the only site in the UK recruiting to this study
TITRATE – Top recruiter for March
ORICAL – 1ST site in the UK to recruit a patient
ATTIRE – met time to target recruited 1st patient in 24 days
Achieved our recruitment target early on the IRISS study
Dr C Chattopadhyay has won the NIHR Lifetime Achievement Award
Dr Gladston Chelliah is Chief Investigator for 2 International Rheumatology Clinical Trials
Exceeded Target in the SIRROUND study
Achieved Target in the ARA-ORBIT Study
Professor Nirmal Kumar appointed the regional lead for ENT research
First site in the UK to screen 2 patients in the REFLECTIONS Clinical Trial
First site in the UK to recruit to the QUIET Study
Winner of the NIHR Award for Most Research Impact
Recently congratulated by the National Institute for Health Research (NIHR) Clinical Research Network for recruiting the first two UK patients to a rheumatoid arthritis study
2nd highest recruiter to B-AHEAD2 Cancer Study, target was 5 patients and we have recruited 24 patients so far
1st global site to open for 2 ENT studies- DYMISTA and QUIET
Fastest site to open globally for DARE a diabetes study
Exceeding target numbers for MAMMO 50, and NCRN452 Cancer Studies
Exceeding target number for the UKGPCS Prostrate trial our target for the length of the trial was 50 and up to date we have 70 with 3 years left to run
Exceeded our target for Chemo Induced Changes in Cognitive Function Study - our target was 3 patients and we managed to recruit 10. This study has now closed
The Rheumatology Research Team have been shortlisted for the NIHR GNCLRN research awards
Tracey Taylor (Research Nurse) has been shortlisted for the Outstanding Contribution to Research Category in the NIHR GMCLRN research awards the awards ceremony is in Manchester on the 30th October 2014
Wrightington Wigan and Leigh NHS Foundation Trust Research Team have been finalists in the National HSJ Awards in London for the last two years
Dr Chattopadhyay (Consultant Rheumatologist and Professor N Kumar (ENT Consultant) have been asked to act as Chief Investigators on two new studies
Usman Butt, Research Fellow Upper Limb Research at Wrightington in collaboration with Professor Ian Trail, David Temperley and Professor Freemont at the University of Manchester, won a prize for the best presentation at a recent British Elbow and Shoulder Society Meeting in Nottingham.
- Performance in Initiating and Delivering Clinical Research
The Government's Plan for Growth, published in October 2022, announced the transformation of incentives at local level for efficiency in initiation and delivery of clinical research.
The National Institute of Health Research (NIHR) has therefore established 2 performance benchmarks that we and other NHS providers are measured against.
As a major UK Clinical Trials Unit with improvement in patient outcomes our primary aim, we are committed to the principle of initiating studies as efficiently as possible and delivering planned recruitment to time and target and therefore we have welcomed these benchmarks.
'Performance in Initiating' Studies
- The two benchmarks are as follows:
- Initiating Clinical Research- the 70 day benchmark
Clinical trials to be set-up and operational within a 70 day period (basically this looks at how quickly studies are set-up and recruited to)
- Delivering Clinical Research- time and target
Recruitment of commercial clinical trials to time and target (basically this looks at whether or not we've recruited the target number of patients in the timeframe we said we would). The overall aim here is to increase the number of patients who have the opportunity to participate in research and to enhance the nation's attractiveness as a host for research.
As a specialist rheumatology centre, we also host quite a lot of clinical trials in this disease , which sometimes means it often takes some time to identify/recruit the first patient and thus the 70-day benchmark is not feasible for some studies..
Our most recent submissions were submitted in April 2022 and are provided below.
National Institute for Health Research Submission List - Link
Performance of Initiating Clinical Trials
Performance of Initiating Studies - Q4 19/20
Performance of Initiating Studies - Q1 20/21
Performance of Initiating Studies - Q2 20/21
Performance of Initiating Studies - Q3 20/21
Performance of Initiating Studies - Q4 20/21
Performance of Initiating Studies - Q1 21/22
Performance of Initiating Studies - Q2 21/22
Performance of Initiating Studies - Q3 21/22
Performance of Initiating Studies - Q4 21/22
Performance of Initiating Studies - Q1 22/23
Performance in Delivering
Performance in Delivering Studies - Q4 19/20
Performance in Delivering Studies - Q1 20/21
Performance in Delivering Studies - Q2 20/21
Performance in Delivering Studies - Q3 20/21
Performance in Delivering Studies - Q4 20/21
Performance in Delivering Studies - Q1 21/22
Performance in Delivering Studies - Q2 21/22
Performance in Delivering Studies - Q3 21/22
Performance in Delivering Studies - Q4 21/22
- Initiating Clinical Research- the 70 day benchmark